These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8799853)

  • 1. Naming in dementia secondary to Parkinson's, Huntington's, and Alzheimer's diseases.
    Frank EM; McDade HL; Scott WK
    J Commun Disord; 1996; 29(3):183-97. PubMed ID: 8799853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confrontation naming impairment in dementia.
    Bayles KA; Tomoeda CK
    Brain Lang; 1983 May; 19(1):98-114. PubMed ID: 6222782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of the naming deficit in Alzheimer's and Huntington's disease.
    Hodges JR; Salmon DP; Butters N
    Brain; 1991 Aug; 114 ( Pt 4)():1547-58. PubMed ID: 1832072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of naming impairment among patients with Parkinson's disease without dementia, Parkinson's disease dementia and Alzheimer's disease].
    Gui XH; Wang LP; Wu CL; Sun XF
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(21):1664-7. PubMed ID: 27290706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
    Pillon B; Dubois B; Agid Y
    Ann N Y Acad Sci; 1991; 640():224-7. PubMed ID: 1837977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of phonemic cueing on confrontation naming in Alzheimer's disease.
    Cerbone B; Massman PJ; Woods SP; York MK
    Clin Neuropsychol; 2020 Feb; 34(2):368-383. PubMed ID: 31030619
    [No Abstract]   [Full Text] [Related]  

  • 7. Spoken language production in Huntington's and Parkinson's diseases.
    Murray LL
    J Speech Lang Hear Res; 2000 Dec; 43(6):1350-66. PubMed ID: 11193957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The disparate effects of Alzheimer's disease and Huntington's disease on semantic memory.
    Rohrer D; Salmon DP; Wixted JT; Paulsen JS
    Neuropsychology; 1999 Jul; 13(3):381-8. PubMed ID: 10447299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
    Pillon B; Dubois B; Ploska A; Agid Y
    Neurology; 1991 May; 41(5):634-43. PubMed ID: 1827513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The characteristics of Parkinson's disease with dementia and Alzheimer's disease with impaired cognitive function].
    Wang LP; Sun XF; Wu CL; Shao JS; Zhong JJ; Guo QH
    Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1035-8. PubMed ID: 21211363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases.
    Claus JJ; Mohr E
    Acta Neurol Scand; 1996 May; 93(5):346-51. PubMed ID: 8800345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impairment of semantic and episodic memory in Alzheimer's and Huntington's diseases: a controlled prospective study.
    Hodges JR; Salmon DP; Butters N
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1089-95. PubMed ID: 2149861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semantic error patterns on the Boston Naming Test in normal aging, amnestic mild cognitive impairment, and mild Alzheimer's disease: is there semantic disruption?
    Balthazar ML; Cendes F; Damasceno BP
    Neuropsychology; 2008 Nov; 22(6):703-9. PubMed ID: 18999343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease.
    Graves LV; Holden HM; Van Etten EJ; Delano-Wood L; Bondi MW; Salmon DP; Corey-Bloom J; Delis DC; Gilbert PE
    J Int Neuropsychol Soc; 2018 Sep; 24(8):833-841. PubMed ID: 30113280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive performance in healthy clinical trial participants and patients with the NeuroCart, a neurodegenerative disease measured with an automated neuropsychological and neurophysiological test battery.
    Prins S; Borghans L; de Kam ML; Groeneveld GJ; van Gerven J
    J Neurol Sci; 2023 Jun; 449():120658. PubMed ID: 37079973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concept of subcortical dementia.
    Huber SJ; Paulson GW
    Am J Psychiatry; 1985 Nov; 142(11):1312-7. PubMed ID: 2932922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.
    Davis MY; Keene CD; Jayadev S; Bird T
    J Huntingtons Dis; 2014; 3(2):209-17. PubMed ID: 25062863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical and subcortical influences on clustering and switching in the performance of verbal fluency tasks.
    Tröster AI; Fields JA; Testa JA; Paul RH; Blanco CR; Hames KA; Salmon DP; Beatty WW
    Neuropsychologia; 1998 Apr; 36(4):295-304. PubMed ID: 9665640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semantic and phonemic sequence effects in random word generation: a dissociation between Alzheimer's and Huntington's disease patients.
    Taylor KI; Salmon DP; Monsch AU; Brugger P
    J Int Neuropsychol Soc; 2005 May; 11(3):303-10. PubMed ID: 15892906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.